Tucson, AZ (PRWEB) October 01, 2013
Surgeons in Phoenix, Arizona, successfully implanted the SynCardia temporary Total Artificial Heart into a 14-year-old boy with biventricular (both sides) heart failure and diffuse clot formation in the left ventricle using diagnostic technology to ensure its proper fit prior to actual surgery. The patient was supported and rehabilitated for 11 days and subsequently transplanted.
The multidisciplinary team determined the SynCardia Heart was the only available choice for the patient because of his conditions, according to a professional paper authored by 15 doctors and professors at Phoenix Children’s Hospital and an Arizona heart transplant center. But the device might have been too large to implant into the teenager’s body.
“Cat-scan imaging of the chest, in conjunction with a virtual 3D modeling system, helped determine whether the SynCardia Total Artificial Heart could actually be placed in the child’s chest,” explained D. Bradford Sanders, chief perfusionist at Phoenix Children’s Hospital and the corresponding author of the report. “It also guided the postoperative course.”
Following the implant, the patient experienced progressive respiratory insufficiency stemming from mucus obstructions in the airway. The team obtained additional chest CTs and virtual 3D modeling to determine there were no blockages of major vascular structures, no evidence of left pulmonary vein compression, and the primary airways were open.
“In selected pediatric patients, the Total Artificial Heart is the assist device of choice for decompensating biventricular heart failure. Commonly encountered VAD (ventricular assist devices) issues, such as valve-related problems, left ventricular clot formation, right heart fai
Copyright©2012 Vocus, Inc.
All rights reserved